Pharmacology of the neuromuscluar junction Flashcards

1
Q

How can neuromuscluar transmission be blocked?

A

a
* Ways to block neuromuscular transmission:

1) Presynaptically, by inhibiting Ach Synthesis (rate-limiting step is choline uptake)
2) Presynaptically by inhibiting Ach release
3) Postsynaptically by interfering with the actions of Ach on the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the methods of presynaptic blockade?

A
  • Local anaesthetics
  • General inhalation anaesthetics
  • Inhibitors of calcium
    • Magnesium ions
    • Some antibiotics
      • AMinoglycosides
  • Neuro toxins
    • β-Bungarotoxin (Taiwanese banded krait)
    • Botulinum toxin (clostridium botulinum):
      • Musclespasticityu
      • Cosmetic
      • Hyperhydrosis - inhibits ACh in nautonomic nervous system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical uses of neuromuscular blocking drugs

A
  • Endotracheal intubation
  • During surgical procedures:
    • To allow surgical access to abdominal cavity
    • To ensure immobility
    • Allow relaxation to reduce displaced fracture or dislocation]Decrease of concentration of general anaesthetic needed
  • Infrequently in intensive care
    • Mechanical ventilation at extremes of hypoxia
  • During electroconvulsive therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the structure of an Nicotinic ACh Receptor

A

The nicotinic Ach receptor consists of 5 subunits and 2 ACh binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Nicotinic ACh receptor?

A
  • It is a pore that allows the movement of sodium and potassium ions across the membrane of a cell when ACh binds to both binding sites and causes a conformation shape change
  • This allows sodium to come into the cell and potassium to move out of the cell
  • When there is a sufficient influx of sodium, it will result in depolarisation of the target muscle cell, allowing an action potential to be generate din the NMJ of the target muscle cell
  • This can then spread across the muscle fibre and induce contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do competitive antagonists do?

A

bind to receptors without activating them and compete with the natural ligand (e.g., acetylcholine) for receptor sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do Competitive antagonists of Nicotinic ACH receptors at the NMJ work?

A
  1. Prevents ACh binging to receptor by occupying site
  2. Decreases the motor end plate potential
  3. Decreases depolarisation of the motor end plate region
  4. No activation of the muscle action potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do agonists of Nicotinic ACh receptors work?

A
  1. Persistent depolarisation of the motor end plate
  2. Prolonged End Plate potential
  3. Prolonged depolarisation of the muscle membrane
  4. Membrane potential above the threshold for the resetting of the voltage- gated sodium channels
  5. Sodium channels remain refractory
  6. No more muscle action potentials generated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the phases in which depolarising blockade works?

A

Phase 1

  • Muscle fasciculations observed then blocked
  • Repolariosation inhibited
  • Voltage gated Na+ channels kept inactivated

Phase 2

  • Prolonged/ Increased exposure to drug
  • Desensitization blovkade
  • Depolarisation cannot occur even in absence of drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is Atracurium metabolised?

A

Hofmann elimination and ester hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drugs are metabolised by plasma cholinesterases?

A

Mivacurium
Suxamethonium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the clinical concern behind plasma cholinesterases?

A

Some patients (due to genetic variations) may have deficient or atypical cholinesterase activity, leading to prolonged paralysis (apnea).
4% of the population: Paralysis lasts about 10 minutes.
0.04% of the population: Paralysis may last hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs are metabolised by Hepatic Metabolism (liver breakdown)

A
  • Pancuronium
    Vecuronium
  • Metabolised in the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drug is not heavily metabolised?

A
  • Rocuronium
  • Unchanged in bile and urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the non-depolarising blockers of the NACh receptors

A
  • Pancuronium
  • Vecuronium
  • Rocuronium
  • Atracurium
  • Mivacurium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the depolarising blocker of the NACh receptor?

A

Suxamethonium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

For PANCURONIUM state:
- Onset
- Duration
- Main side effects

A
  • Medium
  • Long
  • Tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For VECURONIUM state:
- Onset
- Duration
- Main side effects

A
  • Medium
  • Medium
  • Few side effects
19
Q

For ROCURONIUM state:
- Onset
- Duration
- Main side effects

A
  • Fast
  • Medium
  • Tachycardia
20
Q

For ATRACURIUM state:
- Onset
- Duration
- Main side effects

A
  • Medium
  • Medium
  • Hypotension
  • Bronchospasm
21
Q

For MIVACURIUM state:
- Onset
- Duration
- Main side effects

A
  • Fast
  • Short
  • Hypotension
  • Bronchospasm
22
Q

For SUXAMETHONIUM state:
- Onset
- Duration
- Main side effects

A
  • fast
  • Short
  • Bradycardia
  • Cardiac dysrhythmias
  • Raised intraocular pressure
  • Postoperative myalgia
  • Malignant hyperthermia
23
Q

Describe Acetylcholinesterase

A
  • True cholinesterase, specific for hydrolysis of Ach
  • Present in conducting tissue and RBCs
  • Bound to basement membrane in the synaptic cleft
24
Q

Describe Plasma cholinesterase

A
  • Pseudocholinesterase, broad spectrum of substrates
  • Widespread distribution
  • Soluble in plasma
25
Q

What are the benefits of Anticholinesterase drugs?

A

Are all inhibitors of cholinesterase enzymes

  • Therefore increased availability of ACh at NMJ by decreased degradation
  • Increases duration of activity of ACh at NMJ
  • More ACh to compete with non-depolarising blockers
26
Q

What is the duration of action of neostigmine

27
Q

What is the mechanism of action for Neostigmine?

A
  • Formation of carbamylated enzyme complex
28
Q

What is the duration of action of Pyyridostigimine

29
Q

What is the mechanism of action of Pyridostigmine?

A

Formation of carbamylated enzyme complex

30
Q

List anticholinesterase drugs

A
  • Neostigmine
  • Pyridostigmine
  • Dyflos
  • Parathion
31
Q

What does carbamylation do?

A

Carbamylation slows the rate of hydrolysis

32
Q

What is the duration of action of Dyflos?

33
Q

What is the duration of action of parathion?

34
Q

What is the mechanism of action of dyflos?

A

Irreversible inhibition

35
Q

What is the mechanism of action of parathion?

A

Irreversible inhibition

36
Q

Describe phosphorylation by dyflos/parathion

A

-highly stable
- recovery depends on synthesis of new enzyme
- Can be coaxed off by pralidoxime

37
Q

What are the effects of anticholinesterases in the CNS?

A
  • Initial excitation with convulsions
  • Unconsciousness and respiratory failure
38
Q

What are the effects of anticholinesterases in the ANS?

A
  • Salivation
  • Lacrimation - secretion of tears
  • Urination
  • Defecation - movement of feces
  • Gastrointestinal upset
  • Emesis - Vomiting
  • Bradycardia
  • Hypotension - Low BP
  • Bronchoconstriction
  • Pupillary constriction
39
Q

How are anticholinesterases used in anaesthesia?

A
  • Reverse non-depolarising muscle blockade
  • Given with atropine or glycopyrrolate to counteract parasympathetic effects
40
Q

How are anticholinesterases used in Myasthenia Gravis?

A
  • Increase neuromuscular transmission
  • Autoantibodies may be produced against the ACh receptor blocking the interaction of the ACh receptor with its ligand (ACh) and leading to increased muscle weakness and death
41
Q

How are anticholinesterases used in glaucoma

A

Decrease intraocular pressure

42
Q

How are anticholinesterases used in alzheimer’s disease?

A

Enhance the choligernic transmission in the CNS

43
Q

What does sugammadex do?

A

Selective binding agent(SRBA); Reverses effects of rocuronium and vecuronium